GlassScriptPhysician profile
Jennifer Hudson
NPI 1265082465
$4,552.51
in general payments reported to CMS, 2019-2025
21 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $679 · 2022: $326 · 2023: $2,901 · 2024: $422 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,916 · Food and Beverage: $1,578 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,916.18 |
| Food and Beverage | $1,578.25 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,559.53 | 2023 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $401.41 | 2024-2025 | Proclaim |
| Abbvie INC. | $364.99 | 2022-2024 | |
| Vifor Pharma, INC. | $218.41 | 2021 | |
| Nalu Medical, INC. | $137.99 | 2024 | Nalu Neurostimulation System |
| Novartis Pharmaceuticals Corporation | $130.87 | 2021-2022 | |
| Novo Nordisk INC | $123.76 | 2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.18 | 2021 | |
| Dexcom, INC. | $80.39 | 2022 | |
| Relievant Medsystems, INC. | $71.87 | 2023 | Intracept |
| Amarin Pharma, INC. | $63.39 | 2021 | |
| Pfizer INC. | $58.39 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.36 | 2021 | |
| Abiomed | $36.12 | 2024 | Impella |
| Kowa Pharmaceuticals America, INC. | $27.83 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.79 | 2021 | |
| Esperion Therapeutics, INC. | $24.43 | 2021 | |
| Tactile Systems Technology INC | $24.28 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.38 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.